Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies
Kim Papp, Kristian Reich, Andrew Blauvelt, Diamant Thaci, Rodney Sinclair, Stephen K Tyring, Nicole Cichanowitz, Stuart Green, Qing Li, Carmen La Rosa
Abstract not available.
Study supported by Merck & Co., Inc.
psoriasis; tildrakizumab; clinical trial
Abstract - 209 Poster PDF - 54
- There are currently no refbacks.